All In Biotech

Drug Trial Radar · NCT03990805

A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis

Multi-center, Randomized, Double-Blind, Placebo Controlled Phase 3 Clinical Trial to Evaluate Efficacy and Safty of Mesenchymal Stem Cells JointStem in Patients With Knee Osteoarthritis

Last checked: Nov 19, 2026Latest source record: Sep 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 260 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

260

Actual

Start

Jun 11, 2019

Primary completion

Dec 15, 2020

Study completion Dec 15, 2020

Sponsor

Lead sponsor
R-BioIndustry
Sponsor type
Industry
First posted
Jun 19, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 20 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.

Conditions

  • Degenerative Arthritis
  • Knee Osteoarthritis

Interventions

  • JOINTSTEMBiological

    JOINTSTEM Autologous Adipose Tissue derived MSCs 1x10\^8cells/(saline), 1 time injection

  • salineDrug

    saline, 1 time injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC) scores from baselineTime frame: 12 weeks, 24 weeks
  2. Change of Visual Analog Scale (VAS) scores from baselineTime frame: 12 weeks, 24 weeks

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Chungbuk National University Hospital

    Cheongju-si, South Korea

  • Yeungnam University Hospital

    Daegu, South Korea

  • Keimyung University Dongsan Medical Center

    Daegu, South Korea

  • Chonbuk National University Hospital

    Jeonju, South Korea

  • Gyeongsang National University Hospital

    Jinju, South Korea

  • Kyunghee University Medical Center

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Yonsei University Health System

    Seoul, South Korea

  • KyungHee University Gangdong Hospital

    Seoul, South Korea

  • Gangnam Severance Hospital

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Seoul St. Mary's Hospital

    Seoul, South Korea

  • Chunang University Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.